Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocugen (OCGN) Shares Outstanding (Weighted Average): 2014-2025

Historic Shares Outstanding (Weighted Average) for Ocugen (OCGN) over the last 11 years, with Sep 2025 value amounting to $292.3 million.

  • Ocugen's Shares Outstanding (Weighted Average) rose 1.54% to $292.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $292.3 million, marking a year-over-year increase of 1.54%. This contributed to the annual value of $291.3 million for FY2024, which is 13.57% up from last year.
  • Latest data reveals that Ocugen reported Shares Outstanding (Weighted Average) of $292.3 million as of Q3 2025, which was up 0.09% from $292.0 million recorded in Q2 2025.
  • Ocugen's Shares Outstanding (Weighted Average)'s 5-year high stood at $292.3 million during Q3 2025, with a 5-year trough of $188.1 million in Q1 2021.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $257.3 million (2024), whereas its average is $266.8 million.
  • Data for Ocugen's Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 257.41% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Ocugen's Shares Outstanding (Weighted Average) stood at $199.2 million in 2021, then increased by 9.89% to $218.9 million in 2022, then rose by 17.18% to $256.5 million in 2023, then grew by 13.57% to $291.3 million in 2024, then rose by 1.54% to $292.3 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $292.3 million in Q3 2025, compared to $292.0 million in Q2 2025 and $292.0 million in Q1 2025.